Following IGF-I treatment of humans and mice suffering from primary growth hormone resistance, serum IGF-I level increased drastically and led to a substantial increase in serum LH, FSH and testicular testosterone [37], [38]. This evidence concerns the gene PLOD1 and Laron syndrome.